Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy
ACS Nano · 2024
DOI: 10.1021/acsnano.4c04553 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Hao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdiscip…. Hauptthemen laut MEDLINE: Glioblastoma, 5'-Nucleotidase, Immunotherapy. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Soochow University, National Key Research and Development Program of China, Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
The currently available immune checkpoint therapy shows a disappointing therapeutic efficacy for glioblastoma multiforme (GBM), and it is of great importance to discover better immune checkpoints and develop innovative targeting strategies. The discovered metabolic immune checkpoint ecto-5-nucleotidase (CD73) in a tumor contributes to its immune evasion due to the dysregulation of extracellular adenosine (ADO), which significantly inhibits the function of antitumor T cells and increases the activity of immunosuppressive cells. Herein, we drastically inhibit the expression of CD73 to reduce the production of ADO by using versatile Au@Cu2-xSe nanoparticles (ACS NPs). ACS NPs can decrease the expression of CD73 by alleviating the tumor hypoxia through their Fenton-like reaction to weaken the ADO-driven immunosuppression for enhancing antitumor T cell infiltration and activity of GBM. The copper ions (Cu2+) released from ACS NPs can chelate with disulfide, leading to the formation of cytotoxic bis(N,N-diethyldithiocarbamate)-copper complex (CuET), which can be combined with radiotherapy to recruit more antitumor T cells to infiltrate into the tumor site. Based on the inhibition of CD73 to promote the infiltration and activity of antitumor T cells, a cascade of enhancing GBM immunotherapy effects can be achieved. The significant increase in CD8+ T and CD4+ T cells within the tumor and the memory T cells in the spleen effectively reduces tumor size by 92%, which demonstrates the excellent efficacy of immunotherapy achieved by a combination of metabolic immune checkpoint CD73 inhibition with chemoradiotherapy. This work demonstrates that modulation of CD73-mediated tumor immunosuppression is an important strategy of improving the outcome of GBM immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation…
- Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou 215025, China.
ORCID-Profile: Zhen Li
Förderung
- Soochow University
- National Key Research and Development Program of China
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection
Zitieren
APA
Zhang, H., Yang, L., Han, M., Han, Y., Jiang, Z., Zheng, Q., Dong, J., Wang, T., & Li, Z. (2024). Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.4c04553
Vancouver
Zhang H, Yang L, Han M, Han Y, Jiang Z, Zheng Q, et al. Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.4c04553
BibTeX
@article{Zhang2024,
author = {Zhang, Hao and Yang, Li and Han, Mengxiao and Han, Yaobao and Jiang, Zhilin and Zheng, Qing and Dong, Jun and Wang, Tingting and Li, Zhen},
title = {Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c04553}
}
EUVIMED